NRIX: Nurix Therapeutics Inc

11.88 USD 0.16 (1.33%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de NRIX a changé de -1.33% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 11.78 et à un maximum de 12.33.

Suivez la dynamique Nurix Therapeutics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

NRIX Nouvelles

Investing 22:57 Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock
Investing 22:54 Nurix Therapeutics’ ring sells $46k in stock to cover tax obligations
Investing 22:52 Nurix Therapeutics CFO van Houte sells $51,695 in shares
Investing 14:58 Morgan Stanley lowers Nurix stock price target to $16 on higher spend
TipRanks 17:03 Top 3 Trending Stocks, According to Analysts – 7/11/2025 - TipRanks.com
Investing 12:12 Stifel maintains Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 11:35 Nurix stock price target lowered to $26 by UBS on increased OpEx
Investing 11:14 Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
Investing 11:04 Stifel reiterates Buy rating on Nurix stock, sees $4.5B peak sales potential
Investing 00:02 Nurix earnings beat by $0.19, revenue topped estimates
Investing 20:19 Nurix Therapeutics beats quarterly expectations on strong collaboration revenue
Investing 11:45 Nurix stock maintains Buy rating at H.C. Wainwright on positive BTK degrader data
Seeking Alpha 01:14 Tracking Baker Brothers Portfolio – Q1 2025 Update
Investing 20:12 Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 13:58 Nurix stock price target reiterated at $30 by UBS on positive trial data
Investing 13:52 Nurix stock price target raised to $28 from $27 at RBC Capital
Investing 11:16 Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chroni
Investing 11:13 Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congr
Investing 11:18 Stifel analysts maintain Buy rating on Nurix stock after SNY deal
Investing 14:31 UnitedHealth, Biontech lead Monday’s market cap stock movers
Investing 12:36 Sanofi extends license option with Nurix’s STAT6 program
Benzinga 12:12 Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Nurix Therapeutics (NASDAQ:NRIX), Blueprint Medicines (NASDAQ:BPMC), Sanofi (NASDAQ:SNY)
Investing 11:08 Nurix secures additional $15 million from Sanofi license deal
Investing 11:24 Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Range quotidien

11.78 12.33

Range Annuel

8.18 29.56

Clôture Précédente: 11.89
Ouverture: 12.04

Bid: 11.88
Ask: 12.18

Plus Bas: 11.78
Plus Haut: 12.33

Volume: 2.183 K

Changement quotidien: -1.33%
Changement Mensuel: 4.30%

Changement à 6 Mois: -38.79%
Changement Annuel: -46.00%

31 juillet, jeudi